Jeremy Wyatt has held progressive leadership roles at ActiGraph since its inception in 2004. He led both the company’s hardware engineering and software development teams and served as the Chief Technology Officer until his appointment as Chief Executive Officer in May 2020.

With two decades of embedded hardware systems development and related cloud technology expertise, Jeremy has a uniquely well-rounded perspective on the challenges and opportunities of deploying wearable technologies to capture accurate and meaningful patient data. He is considered an industry thought leader and expert in the clinical biosensor space and is a frequent representative and contributor at clinical drug development commercial events, scientific consortiums, and FDA/EMA regulatory meetings.

Jeremy is a member and contributor to the Digital Medicine (DiMe) Society and participates in various digital biomarker efforts with the Clinical Trial Transformation Initiative (CTTI). He has an undergraduate degree in electrical engineering from the University of Florida and an MBA from the University of West Florida.